文献速递流行病学与生物统计临床试验与 GCP

持续气道正压通气治疗依从性与复发性心血管事件风险:一项Meta分析

Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis.
PubMed 文献 · JAMA · 2023-01-01

该研究通过个体参与者数据Meta分析评估持续气道正压通气(CPAP)对阻塞性睡眠呼吸暂停(OSA)合并心血管疾病患者不良心血管事件的影响。共纳入4186例参与者,CPAP组与非CPAP组主要不良心脑血管事件(MACCE)风险相似(HR 1.01,95%CI 0.87-1.17);但依从性良好(≥4小时/天)与MACCE风险降低相关(HR 0.69,95%CI 0.52-0.92)。

要点

  • CPAP治疗与非CPAP组MACCE风险无显著差异(HR 1.01,95%CI 0.87-1.17)。
  • 依从性良好(≥4小时/天)与MACCE风险降低相关(HR 0.69,95%CI 0.52-0.92)。
  • 治疗依从性是OSA患者心血管二级预防的关键因素。

核心结论

  • CPAP治疗依从性与复发性MACCE风险降低相关,提示治疗依从性是OSA患者心血管二级预防的关键因素。

研究设计与样本

  • 研究为随机临床试验的个体参与者数据Meta分析,系统检索截至2023年6月22日。
  • 共纳入4186例参与者(82.1%男性;平均[SD]体重指数28.9[4.5];平均[SD]年龄61.2[8.7]岁;平均[SD]呼吸暂停低通气指数31.2[17]次/小时;71%患高血压)。
  • 50.1%接受CPAP(平均[SD]依从性3.1[2.4]小时/天),49.9%未接受CPAP(常规护理),平均[SD]随访3.25[1.8]年。
  • 采用一阶段和二阶段IPD Meta分析,混合效应Cox回归模型估计CPAP对MACCE风险的影响。
  • 另采用边际结构Cox模型联合逆概率治疗加权进行在治疗分析,评估良好依从性(≥4小时/天)的效果。

主要发现

  • 主要结局为首次MACCE,CPAP组与非CPAP组相似(HR 1.01,95%CI 0.87-1.17)。
  • 在治疗分析显示,良好依从CPAP与MACCE风险降低相关(HR 0.69,95%CI 0.52-0.92)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The effect of continuous positive airway pressure (CPAP) on secondary cardiovascular disease prevention is highly debated. OBJECTIVE: To assess the effect of CPAP treatment for obstructive sleep apnea (OSA) on the risk of adverse cardiovascular events in randomized clinical trials. DATA SOURCES: PubMed (MEDLINE), EMBASE, Current Controlled Trials: metaRegister of Controlled Trials, ISRCTN Registry, European Union clinical trials database, CENTRAL (Cochrane Central Register of Controlled Trials), and ClinicalTrials.gov databases were systematically searched through June 22, 2023. STUDY SELECTION: For qualitative and individual participant data (IPD) meta-analysis, randomized clinical trials addressing the therapeutic effect of CPAP on cardiovascular outcomes and mortality in adults with cardiovascular disease and OSA were included. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently screened records, evaluated potentially eligible primary studies in full text, extracted data, and cross-checked errors. IPD were requested from authors of the selected studies (SAVE [NCT00738179], ISAACC [NCT01335087], and RICCADSA [NCT00519597]). MAIN OUTCOMES AND MEASURES: One-stage and 2-stage IPD meta-analyses were completed to estimate the effect of CPAP treatment on risk of recurrent major adverse cardiac and cerebrovascular events (MACCEs) using mixed-effect Cox regression models. Additionally, an on-treatment analysis with marginal structural Cox models using inverse probability of treatment weighting was fitted to assess the effect of good adherence to CPAP (≥4 hours per day). RESULTS: A total of 4186 individual participants were evaluated (82.1% men; mean [SD] body mass index, 28.9 [4.5]; mean [SD] age, 61.2 [8.7] years; mean [SD] apnea-hypopnea index, 31.2 [17] events per hour; 71% with hypertension; 50.1% receiving CPAP [mean {SD} adherence, 3.1 {2.4} hours per day]; 49.9% not receiving CPAP [usual care], mean [SD] follow-up, 3.25 [1.8] years). The main outcome was defined as the first MACCE, which was similar for the CPAP and no CPAP groups (hazard ratio, 1.01 [95% CI, 0.87-1.17]). However, an on-treatment analysis by marginal structural model revealed a reduced risk of MACCEs associated with good adherence to CPAP (hazard ratio, 0.69 [95% CI, 0.52-0.92]). CONCLUSIONS AND RELEVANCE: Adherence to CPAP was associated with a reduced MACCE recurrence risk, suggesting that treatment adherence is a key factor in secondary cardiovascular prevention in patients with OSA.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Sánchez-de-la-Torre M, Gracia-Lavedan E, Benitez ID, et al. Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis. JAMA. 2023. PMID: 37787793. doi:10.1001/jama.2023.17465

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。